Immunic (IMUX) Operating Leases (2019 - 2026)

Immunic has reported Operating Leases for 8 years, with the latest figure at $421000.0 in Q1 2026.

• Quarterly Operating Leases fell 56.82% year-over-year to $421000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $421000.0 (down 56.82% YoY) and the FY2025 annual result came in at $107000.0, down 59.47% from the prior year.
• Operating Leases improved to $421000.0 in Q1 2026 per IMUX's latest filing, from $107000.0 in the prior quarter.
• Over five years, Operating Leases peaked at $2.0 million in Q1 2023 and troughed at $107000.0 in Q4 2025.
• A 5-year average of $785705.9 and a median of $759000.0 in 2022 frame the typical range for Operating Leases.
• The sharpest annual moves came in 2023 and 2024: Operating Leases soared 298.61% in 2023, then sank 87.18% in 2024.
• Over 5 years, Operating Leases stood at $992000.0 in 2022, then plunged by 35.58% to $639000.0 in 2023, then sank by 58.69% to $264000.0 in 2024, then plunged by 59.47% to $107000.0 in 2025, then jumped by 293.46% to $421000.0 in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $421000.0, $107000.0, and $126000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.